Department of Neurology, University Hospital Knappschaftskrankenhaus, Ruhr University Bochum, Bochum, Germany.
Eur Neurol. 2012;67(4):193-9. doi: 10.1159/000334724. Epub 2012 Feb 24.
Recanalizing therapy in ischemic stroke is restricted to thrombolysis within 3 h. Multimodal imaging of vessel and parenchymal perfusion status may allow the extension of this time window.
To retrospectively analyze treatment results of any recanalizing therapy in clinical practice.
Patients comprised three groups: 'standard' intravenous thrombolysis within 3 h; 'off-label' intravenous thrombolysis, and off-label interventional therapy. Recanalizing therapy was applied dependent on multimodal CT according to standardized pathways. Short-term clinical courses were analyzed.
Of 543 patients (ischemic stroke, TIA), 68 (12.5%) received some type of recanalizing therapy. Of these, 47 (mean age 73.4, 24 female, mean symptom onset and hospital admission 62 min) received standard and 10 off-label thrombolysis (70.8, 6 female, 332 min), and 11 interventional therapy, mostly mechanical thrombectomy (mean age 62.5, 7 female, 186 min). Mean Δ short-term National Institutes of Health Stroke Scale (2-5 days) in these three groups were 3.7 ± 4.7, 3.9 ± 4.4, and 4.1 ± 5.8, respectively. The short-term clinical benefit was similar in the three groups.
Off-label therapy is considered to have a higher risk of complications. However, if multimodal CT imaging of acute ischemic stroke is incorporated in everyday clinical decision-making, the rate of effective recanalizing procedures may be increased without an apparent negative effect on short-term outcome.
缺血性脑卒中的再通治疗仅限于 3 小时内的溶栓治疗。血管和实质灌注状态的多模态成像可能允许延长这个时间窗。
回顾性分析临床实践中任何再通治疗的治疗效果。
患者分为三组:“标准”3 小时内静脉溶栓;“超适应证”静脉溶栓和超适应证介入治疗。根据标准化途径,再通治疗取决于多模态 CT 进行应用。分析短期临床过程。
在 543 例(缺血性脑卒中、短暂性脑缺血发作)患者中,68 例(12.5%)接受了某种类型的再通治疗。其中,47 例(平均年龄 73.4 岁,24 例女性,平均症状发作和入院时间为 62 分钟)接受了标准和 10 例超适应证溶栓治疗(70.8 岁,6 例女性,332 分钟),11 例接受了介入治疗,主要是机械血栓切除术(平均年龄 62.5 岁,7 例女性,186 分钟)。这三组患者在 2-5 天内的短期 NIHSS 平均差值分别为 3.7±4.7、3.9±4.4 和 4.1±5.8。三组的短期临床获益相似。
超适应证治疗被认为有更高的并发症风险。然而,如果将急性缺血性脑卒中的多模态 CT 成像纳入日常临床决策,有效再通治疗的比例可能会增加,而对短期结局没有明显的负面影响。